The use of interleukine-1 inhibitors in familial Mediterranean fever patients: a narrative review

V Hentgen, C Vinit, A Fayand… - Frontiers in …, 2020 - frontiersin.org
Purpose: Familial Mediterranean fever (FMF) is the most common monogenic auto-
inflammatory disease characterized by recurrent attacks of fever and serositis. It is …

[PDF][PDF] IL-1 inhibition in familial Mediterranean fever: clinical outcomes and expectations

F Kharouf, T Tsemach-Toren… - Clin Exp …, 2022 - clinexprheumatol.org
Familial Mediterranean fever (FMF) is a hereditary auto-inflammatory disease, characterised
by recurrent episodes of fever and serositis. Since 1972, colchicine has been the drug of …

Ocular involvement in monogenic autoinflammatory disease

I Maccora, E Marrani, MV Mastrolia… - Autoimmunity …, 2021 - Elsevier
Abstract Objective Monogenic Autoinflammatory diseases (AIDs) are a broad spectrum of
rare hereditary diseases whose ocular involvement has not been well characterized yet …

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)

G El Hasbani, A Jawad, I Uthman - Orphanet journal of rare diseases, 2019 - Springer
Abstract Background Familial Mediterranean Fever (FMF), an autoinflammatory disease, is
characterized by self-limited inflammatory attacks of fever and polyserositis along with high …

Amyloidosis and glomerular diseases in familial Mediterranean fever

R Siligato, G Gembillo, V Calabrese, G Conti… - Medicina, 2021 - mdpi.com
Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease with autosomal
recessive transmission, characterized by periodic fever attacks with self-limited serositis …

The efficacy, safety and tolerability of canakinumab in the treatment of familial Mediterranean fever: a systematic review of the literature

M Kacar, S Savic, JCH van der Hilst - Journal of inflammation …, 2020 - Taylor & Francis
Abstract Familial Mediterranean Fever (FMF) is the most prevalent genetic autoinflammatory
disorder. In most patients, treatment with colchicine can prevent attacks of fever and …

A narrative review on the role of cytokines in the pathogenesis and treatment of familial Mediterranean fever: an emphasis on pediatric cases

A Chaaban, H Yassine, R Hammoud, R Kanaan… - Frontiers in …, 2024 - frontiersin.org
Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease characterized
by an early onset of recurrent fever and serositis episodes. FMF is caused by mutations in …

Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis

B Kilic, Y Guler, FN Azman, E Bostanci… - Rheumatology, 2024 - academic.oup.com
Objectives FMF is the most common hereditary monogenic fever syndrome marked by
recurrent attacks of fever and polyserositis. Colchicine is the current recommended first-line …

Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease

D Poddighe, M Romano… - British journal of …, 2022 - Wiley Online Library
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease and is usually diagnosed in childhood, especially in the first decade of life …

The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

T Coşkuner, Ş Çağlayan, Ö Akgün… - Expert opinion on …, 2023 - Taylor & Francis
Objective To evaluate the safety of canakinumab using real-world data in patients with
systemic juvenile idiopathic arthritis (sJIA) and autoinflammatory diseases (AID). Research …